What’s New in HIV/AIDS

In the face of a global epidemic of HIV/AIDS with the majority of individuals living in developing countries a protective vaccine seems the foremost goal. As this is not within imminent reach the other option would be an immunotherapy that prolongs the asymptomatic phase of infection. The basis for such a therapy is to understand the correlates of protective immunity against HIV. Here we present the most recent advances regarding selected parts of the immune response towards HIV. (authors)